Neumora Therapeutics, Inc. (NMRA)
0.8313
-0.17
(-16.82%)
USD |
NASDAQ |
Sep 15, 16:00
0.8301
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Market Cap : 155.33M for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 155.33M |
| September 14, 2026 | 186.74M |
| September 11, 2026 | 194.32M |
| September 10, 2026 | 213.01M |
| September 09, 2026 | 224.22M |
| September 08, 2026 | 233.56M |
| September 04, 2026 | 244.77M |
| September 03, 2026 | 252.25M |
| September 02, 2026 | 257.85M |
| September 01, 2026 | 248.51M |
| August 31, 2026 | 248.51M |
| August 28, 2026 | 259.72M |
| August 27, 2026 | 276.54M |
| August 26, 2026 | 291.49M |
| August 25, 2026 | 280.28M |
| August 24, 2026 | 284.95M |
| August 21, 2026 | 304.57M |
| August 20, 2026 | 283.08M |
| August 19, 2026 | 306.44M |
| August 18, 2026 | 306.44M |
| August 17, 2026 | 284.01M |
| August 14, 2026 | 298.96M |
| August 13, 2026 | 323.25M |
| August 12, 2026 | 319.52M |
| August 11, 2026 | 317.65M |
| Date | Value |
|---|---|
| August 10, 2026 | 295.09M |
| August 07, 2026 | 296.92M |
| August 06, 2026 | 298.74M |
| August 05, 2026 | 293.27M |
| August 04, 2026 | 291.45M |
| August 03, 2026 | 298.74M |
| July 31, 2026 | 293.27M |
| July 30, 2026 | 300.56M |
| July 29, 2026 | 300.56M |
| July 28, 2026 | 306.02M |
| July 27, 2026 | 302.38M |
| July 24, 2026 | 271.41M |
| July 23, 2026 | 284.16M |
| July 22, 2026 | 280.52M |
| July 21, 2026 | 294.18M |
| July 20, 2026 | 296.92M |
| July 17, 2026 | 293.27M |
| July 16, 2026 | 291.45M |
| July 15, 2026 | 296.92M |
| July 14, 2026 | 287.81M |
| July 13, 2026 | 291.45M |
| July 10, 2026 | 306.02M |
| July 09, 2026 | 300.56M |
| July 08, 2026 | 289.63M |
| July 07, 2026 | 315.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 643.48B |
| Indivior Pharmaceuticals, Inc. | 4.038B |
| Liquidia Corp. | 5.856B |
| BioAge Labs, Inc. | 374.46M |
| LB Pharmaceuticals, Inc. | 1.234B |
Market Cap Related Metrics
| Price to Book Value | 3.489 |
| Price | 0.8313 |
| Earnings Yield | -148.4% |